AR039317A1 - Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion - Google Patents

Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion

Info

Publication number
AR039317A1
AR039317A1 ARP030101350A ARP030101350A AR039317A1 AR 039317 A1 AR039317 A1 AR 039317A1 AR P030101350 A ARP030101350 A AR P030101350A AR P030101350 A ARP030101350 A AR P030101350A AR 039317 A1 AR039317 A1 AR 039317A1
Authority
AR
Argentina
Prior art keywords
preparation
suspension
sterile
inhalation administration
sterile suspension
Prior art date
Application number
ARP030101350A
Other languages
English (en)
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of AR039317A1 publication Critical patent/AR039317A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Abstract

Uso de un turboemulsificador, comenzando a partir de un ingrediente activo estéril micronizado. Reivindicación 1: Un proceso para la preparación de suspensiones útil para preparar formulaciones farmacéuticas para inhalación por nebulización, caracterizado porque comprende los siguientes pasos: a) agregar uno o más ingredientes activos, bajo la forma de un polvo estéril micronizado, a una solución acuosa que constituye el vehículo, en un turboemulsificador equipado con una turbina de alto poder y conectado a una tolva de carga, introduciendo dichos ingredientes activos a través de la turbina después de aplicar vacío; b) homogeneizar el ingrediente activo en la suspensión, aún al vacío, usando el sistema de turbina; c) distribuir la suspensión obtenida de este modo en recipientes adecuados, tales como recipientes para dosis individuales.
ARP030101350A 2002-04-17 2003-04-16 Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion AR039317A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000808A ITMI20020808A1 (it) 2002-04-17 2002-04-17 Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione

Publications (1)

Publication Number Publication Date
AR039317A1 true AR039317A1 (es) 2005-02-16

Family

ID=11449718

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101350A AR039317A1 (es) 2002-04-17 2003-04-16 Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion

Country Status (25)

Country Link
US (1) US7541021B2 (es)
EP (1) EP1494647B1 (es)
CN (1) CN1292733C (es)
AR (1) AR039317A1 (es)
AT (1) ATE338539T1 (es)
AU (1) AU2003227627A1 (es)
BR (1) BRPI0304821B8 (es)
CA (1) CA2481520C (es)
CY (1) CY1105800T1 (es)
DE (1) DE60308164T2 (es)
DK (1) DK1494647T3 (es)
EA (1) EA007629B1 (es)
ES (1) ES2272987T3 (es)
HK (1) HK1079986B (es)
HR (1) HRP20040964A2 (es)
IT (1) ITMI20020808A1 (es)
MA (1) MA27194A1 (es)
MX (1) MXPA04010117A (es)
PE (1) PE20030948A1 (es)
PL (1) PL207863B1 (es)
PT (1) PT1494647E (es)
SI (1) SI1494647T1 (es)
UA (1) UA79453C2 (es)
WO (1) WO2003086347A1 (es)
ZA (1) ZA200408319B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1572217E (pt) * 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
PL1670482T5 (pl) * 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
DE602004017342D1 (de) * 2003-10-23 2008-12-04 Otsuka Pharma Co Ltd Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
EP1740188A1 (en) * 2004-04-20 2007-01-10 Altana Pharma AG Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
EP1683514B1 (en) 2005-01-20 2012-05-23 Eratech S.r.l. Process for the preparation of concentrated suspensions of drugs and kit thereof
JP2009508859A (ja) * 2005-09-15 2009-03-05 エラン ファーマ インターナショナル リミテッド ナノ粒子アリピプラゾール製剤
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
JP2009526860A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー 安定したコルチコステロイド混合物
EP2170348B1 (en) * 2007-06-22 2016-08-10 Dompé farmaceutici s.p.a. Effervescent tablets for inhalatory use
NZ582415A (en) * 2007-07-31 2012-05-25 Otsuka Pharma Co Ltd Methods for producing aripiprazole suspension and freeze-dried formulation
CN102475708A (zh) * 2010-11-23 2012-05-30 天津金耀集团有限公司 丙酸氟替卡松和含辅料的水构成的治疗皮肤病的分离式水混悬剂药物
CN102657659A (zh) * 2010-11-23 2012-09-12 天津金耀集团有限公司 皮肤用含有辅料的丙酸氟替卡松与含有辅料的水的透皮吸收药物
CN103501791B (zh) * 2011-05-03 2016-05-18 奇斯药制品公司 用于通过吸入给药的改良皮质类固醇悬浮制剂
CN103505412A (zh) * 2012-06-26 2014-01-15 上海臣邦医药科技有限公司 一种吸入用丙酸氟替卡松混悬液的制备方法
WO2022098321A1 (en) * 2020-11-09 2022-05-12 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilised suspensions for the administration by inhalation
WO2022231533A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization
WO2022231531A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization
WO2023022672A2 (en) * 2021-08-18 2023-02-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of homogeneous suspensions for the inhalation by nebulization

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.

Also Published As

Publication number Publication date
DK1494647T3 (da) 2007-01-15
MA27194A1 (fr) 2005-01-03
US7541021B2 (en) 2009-06-02
SI1494647T1 (sl) 2007-02-28
EA007629B1 (ru) 2006-12-29
ITMI20020808A0 (it) 2002-04-17
DE60308164T2 (de) 2007-08-09
HK1079986B (zh) 2007-05-11
EP1494647B1 (en) 2006-09-06
MXPA04010117A (es) 2004-12-13
ITMI20020808A1 (it) 2003-10-17
BRPI0304821B8 (pt) 2021-05-25
CA2481520C (en) 2011-02-22
ZA200408319B (en) 2006-03-29
HRP20040964A2 (en) 2005-02-28
UA79453C2 (en) 2007-06-25
PL207863B1 (pl) 2011-02-28
PE20030948A1 (es) 2004-01-19
CN1652748A (zh) 2005-08-10
CN1292733C (zh) 2007-01-03
EA200401209A1 (ru) 2005-10-27
PT1494647E (pt) 2007-01-31
CA2481520A1 (en) 2003-10-23
BR0304821A (pt) 2004-06-15
ATE338539T1 (de) 2006-09-15
ES2272987T3 (es) 2007-05-01
WO2003086347A1 (en) 2003-10-23
PL373331A1 (en) 2005-08-22
US20050175546A1 (en) 2005-08-11
BRPI0304821B1 (pt) 2018-11-06
EP1494647A1 (en) 2005-01-12
DE60308164D1 (de) 2006-10-19
CY1105800T1 (el) 2011-02-02
AU2003227627A1 (en) 2003-10-27
HK1079986A1 (en) 2006-04-21

Similar Documents

Publication Publication Date Title
AR039317A1 (es) Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion
HRP20170014T1 (hr) Farmaceutski pripravak za inhalaciju
AR057180A1 (es) Formulacion farmaceutica de absorcion oral que comprende insulina, entre otros, y su metodo de administracion
TR200101209T2 (tr) Teneffüs yoluyla uygulanan ilaç parçacıklarının süspansiyonlarının hazırlanması için bir işlem
MX340924B (es) Composiciones farmaceuticas.
BRPI0508170A (pt) formulações farmacêuticas para inaladores de pó seco, que compreendem um ingrediente ativo de potência de baixa dosagem
JP2013538214A5 (es)
ES2103946T3 (es) Excipiente farmaceutico.
AR018891A1 (es) Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol
JP2012517987A5 (ja) 吸入用の医薬組成物のfpd特性を設定する方法
MX2015014337A (es) Composicion que comprende al menos dos polvos secos obtenidos por secado por pulverizacion para incrementar la estabilidad de la formulacion.
BR0316908A (pt) Preparo de suspensões aquosas estéreis incluindo ingredientes ativos cristalinos micronizados para inalação
AR091161A1 (es) Composicion farmaceutica para inhalacion, metodo, uso
PE20061007A1 (es) Proceso para elaborar lactosa utilizando tecnicas pre-clasificacion y formulaciones farmaceuticas formadas a partir de ella
CA3162623A1 (en) Aerosolization systems, methods, and apparatuses
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
RS54874B1 (sr) Upotreba kompozicije koja obuhvata formoterol i beklometazon dipropionat za tretman egzacerbacije astme
MX2015015150A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
MY191712A (en) Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
BRPI0607990A2 (pt) formulação de um aerossol farmacêutico para inaladores dosimetrados pressurizados contendo um agente seqüestrante, uso do agente sequestrante, inalador de dosimetrado pressurizado e método de preenchimento do inalador de aerossol
EA200500387A1 (ru) Композиции для ингаляции с высоким содержанием лекарственных веществ
AU2014226192A8 (en) Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
AR038764A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
Moskovitz et al. Effect of Diclofenac Sodium (Voltaren) and Prostaglandin E (2) on Spermatogenesis in Mature Dogs
CL2020001939A1 (es) Administración de dosis elevadas de terapias inhaladas.

Legal Events

Date Code Title Description
FB Suspension of granting procedure